Literature DB >> 23658453

A chemokine-like viral protein enhances alpha interferon production by plasmacytoid dendritic cells but delays CD8+ T cell activation and impairs viral clearance.

Matthew E Wikstrom1, Peter Fleming, Iain Comerford, Shaun R McColl, Christopher E Andoniou, Mariapia A Degli-Esposti.   

Abstract

Murine cytomegalovirus encodes numerous proteins that act on a variety of pathways to modulate the innate and adaptive immune responses. Here, we demonstrate that a chemokine-like protein encoded by murine cytomegalovirus activates the early innate immune response and delays adaptive immunity, thereby impairing viral clearance. The protein, m131/129 (also known as MCK-2), is not required to establish infection in the spleen; however, a mutant virus lacking m131/129 was cleared more rapidly from this organ. In the absence of m131/129 expression, there was enhanced activation of dendritic cells (DC), and virus-specific CD8(+) T cells were recruited into the immune response earlier. Viral mutants lacking m131/129 elicited weaker production of alpha interferon (IFN-α) at 40 h postinfection, indicating that this protein exerts its effects during early rounds of viral replication in the spleen. Furthermore, while wild-type and mutant viruses activated plasmacytoid dendritic cells (pDC) equally at this time, as measured by the upregulation of costimulatory molecules, the presence of m131/129 stimulated more pDC to secrete IFN-α, accounting for the stronger IFN-α response than from the wild-type virus. These data provide evidence for a novel immunomodulatory function of a viral chemokine and expose the multifunctionality of immune evasion proteins. In addition, these results broaden our understanding of the interplay between innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23658453      PMCID: PMC3700200          DOI: 10.1128/JVI.00187-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Cutting edge: rapid in vivo killing by memory CD8 T cells.

Authors:  Daniel L Barber; E John Wherry; Rafi Ahmed
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

2.  Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus.

Authors:  G M Keil; M R Fibi; U H Koszinowski
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes.

Authors:  M J Reddehase; J B Rothbard; U H Koszinowski
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

4.  A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system.

Authors:  Rachel E Kohler; Adriana C Caon; David O Willenborg; Ian Clark-Lewis; Shaun R McColl
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

5.  Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes.

Authors:  Gabriele Hahn; Maria Grazia Revello; Marco Patrone; Elena Percivalle; Giulia Campanini; Antonella Sarasini; Markus Wagner; Andrea Gallina; Gabriele Milanesi; Ulrich Koszinowski; Fausto Baldanti; Giuseppe Gerna
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.

Authors:  J S Orange; C A Biron
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

7.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

Authors:  T A Cha; E Tom; G W Kemble; G M Duke; E S Mocarski; R R Spaete
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.

Authors:  M T Heise; H W Virgin
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice.

Authors:  J E Allan; G R Shellam
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen.

Authors:  A A Scalzo; N A Fitzgerald; A Simmons; A B La Vista; G R Shellam
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  6 in total

1.  Mck2-dependent infection of alveolar macrophages promotes replication of MCMV in nodular inflammatory foci of the neonatal lung.

Authors:  F R Stahl; K A Keyser; K Heller; Y Bischoff; S Halle; K Wagner; M Messerle; R Förster
Journal:  Mucosal Immunol       Date:  2014-06-04       Impact factor: 7.313

2.  Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice.

Authors:  Lisa P Daley-Bauer; Linda J Roback; Grace M Wynn; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

3.  Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread.

Authors:  Niels A W Lemmermann; Astrid Krmpotic; Jürgen Podlech; Ilija Brizic; Adrian Prager; Heiko Adler; Astrid Karbach; Yiquan Wu; Stipan Jonjic; Matthias J Reddehase; Barbara Adler
Journal:  PLoS Pathog       Date:  2015-02-06       Impact factor: 6.823

4.  Control of primary mouse cytomegalovirus infection in lung nodular inflammatory foci by cooperation of interferon-gamma expressing CD4 and CD8 T cells.

Authors:  Yvonne Lueder; Katrin Heller; Christiane Ritter; Kirsten A Keyser; Karen Wagner; Xiaokun Liu; Martin Messerle; Felix R Stahl; Stephan Halle; Reinhold Förster
Journal:  PLoS Pathog       Date:  2018-08-28       Impact factor: 6.823

5.  Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus.

Authors:  Clément Cocita; Rachel Guiton; Gilles Bessou; Lionel Chasson; Marilyn Boyron; Karine Crozat; Marc Dalod
Journal:  PLoS Pathog       Date:  2015-05-08       Impact factor: 6.823

Review 6.  The role of antigen-presenting cells in the pathogenesis of COVID-19.

Authors:  Rana Farzi; Parisa Shiri Aghbash; Narges Eslami; Arezou Azadi; Ali Shamekh; Nima Hemmat; Taher Entezari-Maleki; Hossein Bannazadeh Baghi
Journal:  Pathol Res Pract       Date:  2022-03-23       Impact factor: 3.309

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.